

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 7.64950210 |
| 2 | glycosphingolipid catabolic process (GO:0046479) | 6.92931333 |
| 3 | oligosaccharide catabolic process (GO:0009313) | 6.81342919 |
| 4 | glycolipid catabolic process (GO:0019377) | 6.23088209 |
| 5 | amino sugar catabolic process (GO:0046348) | 5.72633445 |
| 6 | ceramide catabolic process (GO:0046514) | 5.54188300 |
| 7 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 5.41921007 |
| 8 | cellular response to thyroid hormone stimulus (GO:0097067) | 5.14016731 |
| 9 | regulation of cholesterol storage (GO:0010885) | 4.92839327 |
| 10 | positive regulation of bone resorption (GO:0045780) | 4.59378052 |
| 11 | positive regulation of bone remodeling (GO:0046852) | 4.59378052 |
| 12 | osteoclast differentiation (GO:0030316) | 4.40478308 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.37360972 |
| 14 | response to peptidoglycan (GO:0032494) | 4.36156490 |
| 15 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 4.27750289 |
| 16 | regulation of monocyte differentiation (GO:0045655) | 4.23995091 |
| 17 | response to thyroid hormone (GO:0097066) | 4.19663629 |
| 18 | membrane lipid catabolic process (GO:0046466) | 4.18979769 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.18785768 |
| 20 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.13698924 |
| 21 | barbed-end actin filament capping (GO:0051016) | 4.13388569 |
| 22 | sphingolipid catabolic process (GO:0030149) | 4.12135048 |
| 23 | pinocytosis (GO:0006907) | 4.06270011 |
| 24 | regulation of mononuclear cell migration (GO:0071675) | 3.88453999 |
| 25 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.88240463 |
| 26 | myeloid dendritic cell differentiation (GO:0043011) | 3.82415803 |
| 27 | positive regulation of leukocyte degranulation (GO:0043302) | 3.78526665 |
| 28 | protein localization to endosome (GO:0036010) | 3.75001569 |
| 29 | glucosamine-containing compound catabolic process (GO:1901072) | 3.73607895 |
| 30 | apoptotic cell clearance (GO:0043277) | 3.72258781 |
| 31 | positive regulation of tissue remodeling (GO:0034105) | 3.55947366 |
| 32 | N-acetylneuraminate metabolic process (GO:0006054) | 3.50610888 |
| 33 | cellular extravasation (GO:0045123) | 3.47288673 |
| 34 | positive regulation of mast cell activation (GO:0033005) | 3.41183609 |
| 35 | myeloid dendritic cell activation (GO:0001773) | 3.40795657 |
| 36 | macrophage differentiation (GO:0030225) | 3.33748595 |
| 37 | regulation of superoxide anion generation (GO:0032928) | 3.31167048 |
| 38 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.29117761 |
| 39 | positive regulation of mast cell degranulation (GO:0043306) | 3.27770156 |
| 40 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.27770156 |
| 41 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.27378420 |
| 42 | decidualization (GO:0046697) | 3.25647390 |
| 43 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.24502226 |
| 44 | regulation of mast cell degranulation (GO:0043304) | 3.20835466 |
| 45 | regulation of monocyte chemotaxis (GO:0090025) | 3.19019149 |
| 46 | regulation of leukocyte degranulation (GO:0043300) | 3.16510152 |
| 47 | ganglioside metabolic process (GO:0001573) | 3.13410746 |
| 48 | keratan sulfate catabolic process (GO:0042340) | 3.12657659 |
| 49 | dendritic cell differentiation (GO:0097028) | 3.12455065 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 3.11425911 |
| 51 | positive regulation of cholesterol efflux (GO:0010875) | 3.10071330 |
| 52 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.09464191 |
| 53 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.06819053 |
| 54 | phagosome maturation (GO:0090382) | 3.05718280 |
| 55 | eosinophil chemotaxis (GO:0048245) | 3.05699849 |
| 56 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.03982250 |
| 57 | regulation of vitamin metabolic process (GO:0030656) | 3.02399917 |
| 58 | monocyte chemotaxis (GO:0002548) | 2.96451078 |
| 59 | immunoglobulin mediated immune response (GO:0016064) | 2.94328997 |
| 60 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.91624915 |
| 61 | peptide catabolic process (GO:0043171) | 2.87449309 |
| 62 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.86975724 |
| 63 | negative regulation of lipid storage (GO:0010888) | 2.86594566 |
| 64 | cellular response to arsenic-containing substance (GO:0071243) | 2.85728003 |
| 65 | T-helper 1 type immune response (GO:0042088) | 2.82904340 |
| 66 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.82090498 |
| 67 | positive regulation of osteoclast differentiation (GO:0045672) | 2.81982926 |
| 68 | granulocyte activation (GO:0036230) | 2.80599419 |
| 69 | hyaluronan catabolic process (GO:0030214) | 2.79901007 |
| 70 | detection of molecule of bacterial origin (GO:0032490) | 2.79530957 |
| 71 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.79118214 |
| 72 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.77418605 |
| 73 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.76478106 |
| 74 | regulation of mast cell activation (GO:0033003) | 2.75498865 |
| 75 | eosinophil migration (GO:0072677) | 2.74654150 |
| 76 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.73928351 |
| 77 | intracellular pH reduction (GO:0051452) | 2.72556623 |
| 78 | positive regulation of antigen processing and presentation (GO:0002579) | 2.70535342 |
| 79 | respiratory burst (GO:0045730) | 2.69860393 |
| 80 | regulation of macrophage chemotaxis (GO:0010758) | 2.68911083 |
| 81 | NIK/NF-kappaB signaling (GO:0038061) | 2.68884292 |
| 82 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.68659094 |
| 83 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.68584736 |
| 84 | pH reduction (GO:0045851) | 2.68025962 |
| 85 | vitamin D metabolic process (GO:0042359) | 2.67015520 |
| 86 | regulation of podosome assembly (GO:0071801) | 2.65873236 |
| 87 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.63621991 |
| 88 | transferrin transport (GO:0033572) | 2.58901999 |
| 89 | regulation of bone resorption (GO:0045124) | 2.58740673 |
| 90 | positive regulation of sterol transport (GO:0032373) | 2.56188592 |
| 91 | positive regulation of cholesterol transport (GO:0032376) | 2.56188592 |
| 92 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.54617222 |
| 93 | negative regulation of monooxygenase activity (GO:0032769) | 2.53119098 |
| 94 | lysosome organization (GO:0007040) | 2.51763186 |
| 95 | lytic vacuole organization (GO:0080171) | 2.51763186 |
| 96 | membrane raft organization (GO:0031579) | 2.50999178 |
| 97 | mannose metabolic process (GO:0006013) | 2.50605458 |
| 98 | myeloid cell activation involved in immune response (GO:0002275) | 2.50410662 |
| 99 | modulation by symbiont of host immune response (GO:0052553) | 2.48615890 |
| 100 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.48615890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 4.47464253 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.39906075 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.36625486 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.15660533 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.69695951 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.47669661 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.39009746 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32547187 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.03010239 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.01966390 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.66723578 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.57401152 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.42264355 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39890661 |
| 15 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.33894699 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.21502201 |
| 17 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.21078341 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.18005216 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.06769929 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.04730748 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.04003197 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.03959090 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 1.96969449 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.94519045 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.89676560 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86358691 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.83237288 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.80441997 |
| 29 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.79495143 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79467512 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.74714274 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.74402487 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.73497379 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69575366 |
| 35 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67618043 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64775367 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64017335 |
| 38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.60786844 |
| 39 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.59987614 |
| 40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.59699848 |
| 41 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.55577104 |
| 42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51310581 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.50732316 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46907189 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44751602 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40733996 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38909634 |
| 48 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37934903 |
| 49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34368290 |
| 50 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34241857 |
| 51 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34075255 |
| 52 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27163870 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26171681 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26014211 |
| 55 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25517107 |
| 56 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24564734 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22966863 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19948550 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19698199 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18139817 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17870081 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.17760641 |
| 63 | MAF_26560356_Chip-Seq_TH1_Human | 1.17299289 |
| 64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16418264 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14459336 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14438366 |
| 67 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.12473956 |
| 68 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.12473956 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11919172 |
| 70 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11426557 |
| 71 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11424043 |
| 72 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.07917587 |
| 73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07316867 |
| 74 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06629037 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06403357 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04176684 |
| 77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03993290 |
| 78 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03615449 |
| 79 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02631743 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02531844 |
| 81 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02304018 |
| 82 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99665899 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98681080 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98036172 |
| 85 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.96137646 |
| 86 | MYC_22102868_ChIP-Seq_BL_Human | 0.95994662 |
| 87 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94410248 |
| 88 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94330863 |
| 89 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.92477640 |
| 90 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91026515 |
| 91 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90549441 |
| 92 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89405571 |
| 93 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.88218043 |
| 94 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87907439 |
| 95 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.87793158 |
| 96 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86756533 |
| 97 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.86205711 |
| 98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86182485 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85931225 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.85028838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.00946422 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 4.14886473 |
| 3 | MP0009840_abnormal_foam_cell | 3.95357294 |
| 4 | MP0003303_peritoneal_inflammation | 3.37294705 |
| 5 | MP0000604_amyloidosis | 3.33731110 |
| 6 | MP0006082_CNS_inflammation | 3.23646690 |
| 7 | MP0003172_abnormal_lysosome_physiology | 3.09512479 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 2.75916925 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.65632663 |
| 10 | MP0002419_abnormal_innate_immunity | 2.53906266 |
| 11 | MP0000343_altered_response_to | 2.50991255 |
| 12 | MP0003436_decreased_susceptibility_to | 2.50427018 |
| 13 | MP0005451_abnormal_body_composition | 2.40133086 |
| 14 | MP0003724_increased_susceptibility_to | 2.37289800 |
| 15 | MP0002877_abnormal_melanocyte_morpholog | 2.34845696 |
| 16 | MP0003329_amyloid_beta_deposits | 2.24334499 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.10925480 |
| 18 | MP0009785_altered_susceptibility_to | 2.10152407 |
| 19 | MP0001853_heart_inflammation | 2.05997383 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.04480846 |
| 21 | MP0002998_abnormal_bone_remodeling | 1.99740006 |
| 22 | MP0003075_altered_response_to | 1.96421353 |
| 23 | MP0005671_abnormal_response_to | 1.93029999 |
| 24 | MP0004510_myositis | 1.91549792 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.91310467 |
| 26 | MP0005025_abnormal_response_to | 1.91147270 |
| 27 | MP0009278_abnormal_bone_marrow | 1.86748412 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.84406746 |
| 29 | MP0005387_immune_system_phenotype | 1.81788935 |
| 30 | MP0001790_abnormal_immune_system | 1.81788935 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.77920543 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.77465682 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.65137468 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.63399530 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.63399530 |
| 36 | MP0009764_decreased_sensitivity_to | 1.56567306 |
| 37 | MP0003690_abnormal_glial_cell | 1.55380092 |
| 38 | MP0003453_abnormal_keratinocyte_physiol | 1.54731717 |
| 39 | MP0002723_abnormal_immune_serum | 1.52587552 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.51368007 |
| 41 | MP0004947_skin_inflammation | 1.50565898 |
| 42 | MP0005365_abnormal_bile_salt | 1.45181004 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.42095324 |
| 44 | MP0003448_altered_tumor_morphology | 1.39844068 |
| 45 | MP0000858_altered_metastatic_potential | 1.37948122 |
| 46 | MP0000685_abnormal_immune_system | 1.37772279 |
| 47 | MP0005310_abnormal_salivary_gland | 1.36856313 |
| 48 | MP0002405_respiratory_system_inflammati | 1.36314050 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.35921924 |
| 50 | MP0006054_spinal_hemorrhage | 1.35905679 |
| 51 | MP0001819_abnormal_immune_cell | 1.35133135 |
| 52 | MP0005257_abnormal_intraocular_pressure | 1.34705948 |
| 53 | MP0008469_abnormal_protein_level | 1.30892962 |
| 54 | MP0003828_pulmonary_edema | 1.28755996 |
| 55 | MP0001800_abnormal_humoral_immune | 1.21332021 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.20704506 |
| 57 | MP0003950_abnormal_plasma_membrane | 1.20615099 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 1.17371974 |
| 59 | MP0005165_increased_susceptibility_to | 1.13847192 |
| 60 | MP0003091_abnormal_cell_migration | 1.13173242 |
| 61 | MP0005166_decreased_susceptibility_to | 1.12716508 |
| 62 | MP0008260_abnormal_autophagy | 1.11231574 |
| 63 | MP0005164_abnormal_response_to | 1.07951959 |
| 64 | MP0000920_abnormal_myelination | 1.05292594 |
| 65 | MP0001849_ear_inflammation | 1.04928557 |
| 66 | MP0002090_abnormal_vision | 1.04504016 |
| 67 | MP0004883_abnormal_blood_vessel | 1.02793373 |
| 68 | MP0005647_abnormal_sex_gland | 0.96946513 |
| 69 | MP0003566_abnormal_cell_adhesion | 0.95891641 |
| 70 | MP0004808_abnormal_hematopoietic_stem | 0.92853331 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 0.91889292 |
| 72 | MP0003279_aneurysm | 0.91135576 |
| 73 | MP0002254_reproductive_system_inflammat | 0.89983482 |
| 74 | MP0000371_diluted_coat_color | 0.89908328 |
| 75 | MP0005023_abnormal_wound_healing | 0.89711718 |
| 76 | MP0010155_abnormal_intestine_physiology | 0.88951184 |
| 77 | MP0003795_abnormal_bone_structure | 0.88593921 |
| 78 | MP0000716_abnormal_immune_system | 0.87162407 |
| 79 | MP0010234_abnormal_vibrissa_follicle | 0.86354116 |
| 80 | MP0005390_skeleton_phenotype | 0.85501699 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.83919211 |
| 82 | MP0003634_abnormal_glial_cell | 0.83200763 |
| 83 | MP0009763_increased_sensitivity_to | 0.83175713 |
| 84 | MP0001727_abnormal_embryo_implantation | 0.81440104 |
| 85 | MP0003195_calcinosis | 0.81379815 |
| 86 | MP0010307_abnormal_tumor_latency | 0.79322874 |
| 87 | MP0008004_abnormal_stomach_pH | 0.77803094 |
| 88 | MP0001542_abnormal_bone_strength | 0.76638429 |
| 89 | MP0003183_abnormal_peptide_metabolism | 0.72791985 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 0.71804768 |
| 91 | MP0002896_abnormal_bone_mineralization | 0.71081316 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.70149633 |
| 93 | MP0001851_eye_inflammation | 0.70070972 |
| 94 | MP0002429_abnormal_blood_cell | 0.70013719 |
| 95 | MP0000249_abnormal_blood_vessel | 0.69579098 |
| 96 | MP0000465_gastrointestinal_hemorrhage | 0.67864582 |
| 97 | MP0003632_abnormal_nervous_system | 0.66514881 |
| 98 | MP0005595_abnormal_vascular_smooth | 0.65190347 |
| 99 | MP0008874_decreased_physiological_sensi | 0.64367030 |
| 100 | MP0000689_abnormal_spleen_morphology | 0.63661684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 9.78494580 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 9.78494580 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 9.78494580 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 6.08455886 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 5.80221804 |
| 6 | Dysostosis multiplex (HP:0000943) | 4.84718632 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.64949906 |
| 8 | Disinhibition (HP:0000734) | 4.63158781 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.61732175 |
| 10 | Loss of speech (HP:0002371) | 4.55642534 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.92812653 |
| 12 | Neurofibrillary tangles (HP:0002185) | 3.90375795 |
| 13 | Axonal loss (HP:0003447) | 3.84933053 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.83537937 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.81534946 |
| 16 | Myocardial infarction (HP:0001658) | 3.79274900 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.75572062 |
| 18 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.75572062 |
| 19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.75572062 |
| 20 | Mucopolysacchariduria (HP:0008155) | 3.63534403 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.63534403 |
| 22 | Eczematoid dermatitis (HP:0000976) | 3.53981252 |
| 23 | Mutism (HP:0002300) | 3.53259680 |
| 24 | Autoimmune thrombocytopenia (HP:0001973) | 3.49635966 |
| 25 | Apathy (HP:0000741) | 3.29102333 |
| 26 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.27233852 |
| 27 | Upper motor neuron abnormality (HP:0002127) | 3.24468402 |
| 28 | Diminished motivation (HP:0000745) | 3.24420424 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.10778155 |
| 30 | Nuclear cataract (HP:0100018) | 3.09430220 |
| 31 | Hepatosplenomegaly (HP:0001433) | 2.93060665 |
| 32 | Cerebral inclusion bodies (HP:0100314) | 2.93027929 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 2.81482850 |
| 34 | Agnosia (HP:0010524) | 2.78699194 |
| 35 | Neuronal loss in central nervous system (HP:0002529) | 2.70543364 |
| 36 | Asymmetric septal hypertrophy (HP:0001670) | 2.59072600 |
| 37 | Metaphyseal irregularity (HP:0003025) | 2.58280634 |
| 38 | Purpura (HP:0000979) | 2.49879975 |
| 39 | Inappropriate behavior (HP:0000719) | 2.48826002 |
| 40 | Progressive neurologic deterioration (HP:0002344) | 2.44446929 |
| 41 | Thick nail (HP:0001805) | 2.39137749 |
| 42 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.34828547 |
| 43 | Multiple enchondromatosis (HP:0005701) | 2.32480748 |
| 44 | Personality changes (HP:0000751) | 2.30756419 |
| 45 | Vertebral compression fractures (HP:0002953) | 2.28404750 |
| 46 | Prolonged neonatal jaundice (HP:0006579) | 2.27883860 |
| 47 | Bone pain (HP:0002653) | 2.26768288 |
| 48 | Increased serum ferritin (HP:0003281) | 2.25426961 |
| 49 | Abnormality of the periventricular white matter (HP:0002518) | 2.23942396 |
| 50 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.23339579 |
| 51 | Cardiomegaly (HP:0001640) | 2.20743916 |
| 52 | Obstructive lung disease (HP:0006536) | 2.18537233 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.18537233 |
| 54 | Pathologic fracture (HP:0002756) | 2.18399343 |
| 55 | Dementia (HP:0000726) | 2.18377904 |
| 56 | Interstitial pulmonary disease (HP:0006530) | 2.18236900 |
| 57 | Thoracic kyphosis (HP:0002942) | 2.17900859 |
| 58 | Protuberant abdomen (HP:0001538) | 2.16501029 |
| 59 | Xanthomatosis (HP:0000991) | 2.12812333 |
| 60 | Poor head control (HP:0002421) | 2.10111940 |
| 61 | Skin nodule (HP:0200036) | 2.07834741 |
| 62 | Petechiae (HP:0000967) | 2.06895946 |
| 63 | Retinal atrophy (HP:0001105) | 2.04791604 |
| 64 | J-shaped sella turcica (HP:0002680) | 2.03680154 |
| 65 | Basal ganglia calcification (HP:0002135) | 2.03057692 |
| 66 | Glomerulonephritis (HP:0000099) | 2.02510450 |
| 67 | Neoplasm of head and neck (HP:0012288) | 2.00717931 |
| 68 | Esophageal neoplasm (HP:0100751) | 2.00717931 |
| 69 | Recurrent skin infections (HP:0001581) | 1.99925995 |
| 70 | Gingivitis (HP:0000230) | 1.97206355 |
| 71 | Global brain atrophy (HP:0002283) | 1.96112278 |
| 72 | Peripheral demyelination (HP:0011096) | 1.94190720 |
| 73 | Stomatitis (HP:0010280) | 1.91109959 |
| 74 | Amyloidosis (HP:0011034) | 1.89923919 |
| 75 | Supranuclear gaze palsy (HP:0000605) | 1.89911307 |
| 76 | Symptomatic seizures (HP:0011145) | 1.89390084 |
| 77 | Prostate neoplasm (HP:0100787) | 1.86757059 |
| 78 | Nausea (HP:0002018) | 1.86051999 |
| 79 | Multiple lipomas (HP:0001012) | 1.79768377 |
| 80 | Abnormality of the lumbar spine (HP:0100712) | 1.78193513 |
| 81 | Increased CSF protein (HP:0002922) | 1.75554780 |
| 82 | Thin bony cortex (HP:0002753) | 1.74605366 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 1.72667491 |
| 84 | Paralysis (HP:0003470) | 1.70996139 |
| 85 | Osteolytic defects of the hand bones (HP:0009699) | 1.70783080 |
| 86 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.70783080 |
| 87 | Spondylolisthesis (HP:0003302) | 1.69834859 |
| 88 | Abnormal trabecular bone morphology (HP:0100671) | 1.61308682 |
| 89 | Abnormality of the thoracic spine (HP:0100711) | 1.60568102 |
| 90 | Hematochezia (HP:0002573) | 1.59154474 |
| 91 | Complement deficiency (HP:0004431) | 1.58280971 |
| 92 | Abnormality of the basal ganglia (HP:0002134) | 1.57724777 |
| 93 | Ovoid vertebral bodies (HP:0003300) | 1.57245884 |
| 94 | Bone cyst (HP:0012062) | 1.56972130 |
| 95 | Tetraparesis (HP:0002273) | 1.56899053 |
| 96 | Progressive visual loss (HP:0000529) | 1.56618846 |
| 97 | Conjunctival telangiectasia (HP:0000524) | 1.55223531 |
| 98 | Recurrent viral infections (HP:0004429) | 1.55103014 |
| 99 | Recurrent fungal infections (HP:0002841) | 1.53538951 |
| 100 | Premature loss of primary teeth (HP:0006323) | 1.53536199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.72796749 |
| 2 | NME2 | 4.43946201 |
| 3 | GRK7 | 3.15732581 |
| 4 | TGFBR2 | 2.69775276 |
| 5 | INSRR | 2.68139677 |
| 6 | BLK | 2.53676882 |
| 7 | TAOK2 | 2.38585963 |
| 8 | MAP3K14 | 2.38307940 |
| 9 | MAP3K3 | 2.17453907 |
| 10 | PIM2 | 2.01201387 |
| 11 | NEK9 | 1.98938978 |
| 12 | TBK1 | 1.97457119 |
| 13 | ABL2 | 1.96560313 |
| 14 | MOS | 1.92778168 |
| 15 | DDR2 | 1.89193589 |
| 16 | MAP2K3 | 1.86656779 |
| 17 | PRPF4B | 1.86368431 |
| 18 | TYK2 | 1.78824004 |
| 19 | MAP3K11 | 1.78056374 |
| 20 | CSK | 1.72772607 |
| 21 | ARAF | 1.65797563 |
| 22 | LIMK1 | 1.63019928 |
| 23 | TESK2 | 1.62542949 |
| 24 | PAK4 | 1.58520907 |
| 25 | FGR | 1.57400939 |
| 26 | RIPK4 | 1.56071897 |
| 27 | CAMKK2 | 1.51942823 |
| 28 | CAMK1D | 1.48536916 |
| 29 | MATK | 1.47993742 |
| 30 | PDK2 | 1.43430530 |
| 31 | TTN | 1.41493873 |
| 32 | ERN1 | 1.41424833 |
| 33 | ZAP70 | 1.39728549 |
| 34 | ACVR1B | 1.38967376 |
| 35 | TESK1 | 1.28382330 |
| 36 | MAP3K13 | 1.28317971 |
| 37 | TAOK1 | 1.27377951 |
| 38 | IKBKB | 1.20179568 |
| 39 | RIPK1 | 1.18978103 |
| 40 | IRAK4 | 1.13889547 |
| 41 | STK10 | 1.12111199 |
| 42 | CDC42BPA | 1.11586140 |
| 43 | PBK | 1.01118407 |
| 44 | CSF1R | 0.99801867 |
| 45 | CDK6 | 0.94424414 |
| 46 | MAP3K5 | 0.93091414 |
| 47 | MAP3K1 | 0.89863543 |
| 48 | TRIB3 | 0.89796843 |
| 49 | IKBKE | 0.86196772 |
| 50 | SCYL2 | 0.85772319 |
| 51 | ERBB4 | 0.84203112 |
| 52 | PDGFRA | 0.83452778 |
| 53 | PIK3CG | 0.83135042 |
| 54 | JAK3 | 0.82797323 |
| 55 | RPS6KA2 | 0.81808941 |
| 56 | MST1R | 0.81740901 |
| 57 | BMPR2 | 0.81146680 |
| 58 | CAMK1G | 0.75608424 |
| 59 | MAP3K8 | 0.72410305 |
| 60 | PDPK1 | 0.70125224 |
| 61 | JAK1 | 0.69095101 |
| 62 | IRAK2 | 0.69013724 |
| 63 | LYN | 0.66798913 |
| 64 | RPS6KL1 | 0.66777328 |
| 65 | RPS6KC1 | 0.66777328 |
| 66 | ADRBK2 | 0.63966390 |
| 67 | MAP4K1 | 0.62846487 |
| 68 | MARK3 | 0.61727109 |
| 69 | KIT | 0.60273141 |
| 70 | BMX | 0.59776345 |
| 71 | FES | 0.59720861 |
| 72 | LATS2 | 0.59353855 |
| 73 | EPHB2 | 0.58906476 |
| 74 | SYK | 0.57594275 |
| 75 | HCK | 0.54407948 |
| 76 | ICK | 0.52607256 |
| 77 | MAPK12 | 0.51950712 |
| 78 | TRPM7 | 0.51132311 |
| 79 | JAK2 | 0.51089650 |
| 80 | RPS6KA6 | 0.48261844 |
| 81 | KSR2 | 0.46912357 |
| 82 | PDK1 | 0.45255500 |
| 83 | LCK | 0.44486700 |
| 84 | ABL1 | 0.44315761 |
| 85 | PRKG2 | 0.42520299 |
| 86 | MAP2K6 | 0.41011751 |
| 87 | PDGFRB | 0.38577705 |
| 88 | TAOK3 | 0.35830256 |
| 89 | CHUK | 0.35712869 |
| 90 | GSK3A | 0.31511616 |
| 91 | MAPK4 | 0.31385528 |
| 92 | MAP3K2 | 0.31218156 |
| 93 | MAPKAPK2 | 0.31037876 |
| 94 | MAP3K6 | 0.30878046 |
| 95 | MAPK7 | 0.27884895 |
| 96 | INSR | 0.27623906 |
| 97 | SGK3 | 0.26432056 |
| 98 | SIK1 | 0.26083319 |
| 99 | CAMK2G | 0.25771250 |
| 100 | DAPK3 | 0.25396364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.63793817 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 4.51686333 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.62576546 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.37411135 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.78341864 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.50221073 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.43159128 |
| 8 | Phagosome_Homo sapiens_hsa04145 | 2.16197875 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.14986805 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.11524961 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09153013 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.09103576 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.95899373 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.89660479 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.87206308 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.67334709 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.62884432 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.59738690 |
| 19 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.54605017 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51605195 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.49973538 |
| 22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.48798647 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.46792291 |
| 24 | Salmonella infection_Homo sapiens_hsa05132 | 1.44831796 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43876508 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.43175782 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.42880929 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34303635 |
| 29 | Galactose metabolism_Homo sapiens_hsa00052 | 1.22650397 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20652176 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19493608 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.18040482 |
| 33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.17613874 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16660423 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.14571278 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.13071785 |
| 37 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.10425513 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.07477420 |
| 39 | Bladder cancer_Homo sapiens_hsa05219 | 1.06618723 |
| 40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06327316 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.06114270 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05093798 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 1.04866925 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03793488 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03675172 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 0.99259705 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99233049 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 0.98951508 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90656549 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86035765 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84806313 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82852081 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.80491254 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.78930889 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77137175 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73634075 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.73182645 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72561153 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69430080 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67735307 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66161923 |
| 62 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65872866 |
| 63 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64053272 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.61366495 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61185987 |
| 66 | Measles_Homo sapiens_hsa05162 | 0.59959334 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59444143 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58001664 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57071642 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.55607060 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53256687 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52968996 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50200622 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.49788806 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49773678 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49561084 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48458347 |
| 78 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.48100615 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46143798 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45808969 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45496016 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45116061 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44889359 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43569130 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40557961 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40242917 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39236387 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.38929300 |
| 89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37548685 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37445697 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36315897 |
| 92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35155309 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32612945 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32594465 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30595371 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29660150 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.28105139 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27791565 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24049016 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.23681197 |

